Login
Toggle navigation
Videos
Categories
Trending
Healthcare
00:10:00
Cutting-Edge Cancer Therapies and Financial Strategies at the Biotech Showcase in San Francisco| Sadesh Seth , CEO, Actinium Pharmaceuticals Inc.
00:10:00
In-depth discussion on neuro therapeutics and strategic priorities for the next 18 months by Actinogen Medical Ltd CEO|Steven Gourlay , CEO, Actinogen Medical Ltd.
00:10:00
Developing Novel Therapy for Neurological Diseases Associated with Dysregulated Brain Cortisol|Steven Gourlay , CEO, Actinogen Medical Ltd.
00:10:00
Biotech CEO presents promising clinical trial results and upcoming milestones |Helen Tuvesson , CEO, Active Biotech AB
00:10:00
Biopharmaceutical CEO discusses promising Phase 3 trial results of a novel antibiotic for Clostridioides difficile Infections with potential market impact exceeding $1B |David P Luci , CEO, Acurx Pharmaceuticals Inc.
00:10:00
Exploring Biotech Advancements and Talent Growth in Washington |Chad Robbin , CEO, Adaptive Biotechnologies.
00:10:00
Pioneering Immune Medicine and Driving Collaborative Health Tech Solutions. |Chad Robbin , CEO, Adaptive Biotechnologies.
00:10:00
Addex Therapeutics' Advancements in Allosteric Modulation and Collaborative Ventures in CNS Pharmaceuticals |Tim DyerCo , CEO, Addex Therapeutics Ltd.
00:10:00
Navigating the Intersection of Politics and Medicine: Insights from a Health Ministry Veteran | Mr. Chi-Hsien Chan, CEO, Adimmune Corp .
00:10:00
Advancing Gene Therapy for Ocular Diseases: Lunar Phase 2 Trial Design and Clinical Significance | Laurent Fischer, CEO, Adverum Biotechnologies Inc .
00:10:00
A Revolutionary Paradigm for Understanding Human Existence| Pier Vincenzo Piazza, CEO, Aelis Farma SA.
00:10:00
Unity and Collaboration: A Holistic Approach to Healthcare |Ahmed Banderker, CEO, Afrocentric Investment Corporation.
00:10:00
Innovative Healthcare Solutions for Greater Accessibility and Affordability |Ahmed Banderker, CEO, Afrocentric Investment Corporation.
00:10:00
Exploring Latest Developments in Biotech Assets and Financial Outlook |Pier Vincenzo Piazza, CEO, Aelis Farma SA.
00:10:00
Biotech Analysts Unveil AI's Impact: Revolutionizing Drug Discovery for a Promising 2024|JEFFREY M. SOLOMON,President, TD Cowen
00:10:00
Innovative Pharmaceutical Company Accelerates Growth and Forges Strategic Partnerships |Hartley Atkinson, CEO, AFT Pharmaceuticals Ltd .
«
1
2
...
41
42
43
44
45
46
47
...
68
69
»